Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Biomaterials industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Application trends
Chapter 3 Biomaterials Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biocompatible and biodegradable materials in medical applications
3.2.1.2 Growing popularity of tissue engineering
3.2.1.3 Advances in nanotechnology and tissue engineering
3.2.1.4 Government initiatives to promote the use of biomaterial products
3.2.2 Industry pitfalls & challenges
3.2.2.1 High development cost for biomaterials
3.2.2.2 Biocompatibility and safety concerns
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Biomaterials Market Size and Forecast, By Product, 2018 - 2032 (USD Million)
5.1 Key trends, by product
5.2 Metallic biomaterials
5.2.1 Titanium & titanium alloys
5.2.2 Stainless steel
5.2.3 Silver
5.2.4 Cobalt-chrome alloys
5.2.5 Gold
5.2.6 Magnesium
5.3 Polymeric biomaterials
5.3.1 Polyester
5.3.2 Silicone rubber
5.3.3 Polyethylene
5.3.4 Polymethymethacrylate
5.3.5 Polyetheretherketone
5.3.6 Nylon
5.3.7 Other polymeric biomaterials
5.4 Ceramic biomaterials
5.4.1 Calcium phosphate
5.4.2 Zirconia
5.4.3 Calcium sulfate
5.4.4 Carbon
5.4.5 Aluminium oxide
5.4.6 Glass
5.5 Natural biomaterials
5.5.1 Hyaluronic acid
5.5.2 Collagen
5.5.3 Silk
5.5.4 Alginates
5.5.5 Fibrin
5.5.6 Gelatin
5.5.7 Cellulose
5.5.8 Chitin
Chapter 6 Biomaterials Market Size and Forecast, By Application, 2018 - 2032 (USD Million)
6.1 Key trends, by application
6.2 Cardiovascular
6.2.1 Implantable cardiac defibrillators
6.2.2 Pacemakers
6.2.3 Stents
6.2.4 Vascular grafts
6.2.5 Sensors
6.2.6 Guidewires
6.2.7 Other cardiovascular applications
6.3 Ophthalmology
6.3.1 Contact lens
6.3.2 Intraocular lens
6.3.3 Ocular tissue replacement
6.3.4 Synthetic corneas
6.3.5 Other ophthalmic applications
6.4 Dental
6.4.1 Dental implants
6.4.2 Tissue regeneration materials
6.4.3 Bone grafts & substitutes
6.4.4 Dental membranes
6.4.5 Other dental applications
6.5 Orthopedic
6.5.1 Joint replacement biomaterials
6.5.2 Orthobiologics
6.5.3 Bioresorbable tissue fixation products
6.5.4 Visco supplementation
6.5.5 Spine biomaterials
6.5.6 Other orthopedic applications
6.6 Wound healing
6.6.1 Fracture healing device
6.6.2 Adhesion barrier
6.6.3 Skin substitutes
6.6.4 Internal tissue sealant
6.6.5 Surgical hemostats
6.6.6 Other wound healing applications
6.7 Plastic surgery
6.7.1 Soft tissue fillers
6.7.2 Facial wrinkle treatment
6.7.3 Craniofacial surgery
6.7.4 Bioengineered skins
6.7.5 Peripheral nerve repair
6.7.6 Acellular dermal matrices
6.7.7 Other plastic surgery applications
6.8 Neurology
6.8.1 Neural stem cell encapsulation
6.8.2 Shunting systems
6.8.3 Hydrogel scaffold for CNS repair
6.8.4 Cortical neural prosthetics
6.8.5 Other neurology applications
6.9 Tissue engineering
6.10 Other applications
Chapter 7 Biomaterials Market Size and Forecast, By Region, 2018 - 2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 BASF SE
8.2 Covestro AG
8.3 ROYAL DSM
8.4 Celanese Corporation
8.5 Carpenter Technology Corporation
8.6 Corbion
8.7 EVONIK INDUSTRIES
8.8 Berkeley Advanced Biomaterials
8.9 CAM Bioceramics B.V.
8.10 CeramTec GmbH
8.11 Noble Biomaterials
8.12 Victrex plc.
8.13 Mitsubishi Chemical Group Corporation.
8.14 CoorsTek Inc.
8.15 Zeus Company Inc.
